BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Spinal Modulation, Inc. Secures $30 Million Series D Financing


6/15/2011 6:25:27 AM

MENLO PARK, Calif.--(BUSINESS WIRE)-- Spinal Modulation, Inc. announced today the completion of its $30 million Series D financing. Medtronic, Inc. joined existing investors DeNovo Ventures, ePlanet/DFJ, InCube Ventures, Johnson & Johnson Development Corporation (JJDC), Kleiner Perkins Caufield & Byers, MedVenture Associates, and Raffles Venture Partners. Spinal Modulation has completed development of the company’s implantable spinal cord stimulator system. Proceeds from the financing will be used to conduct clinical trials both in the United States and internationally. Additionally, the company plans to commence commercialization outside the United States in the near future.

“I am very pleased to have Medtronic join our current investors in this round of financing. We are encouraged by the early clinical results with our fully implantable system and look forward to providing physicians new options to care for their patients suffering from chronic pain,” said David Wood, President and CEO of Spinal Modulation, Inc.

Mir Imran, Spinal Modulation’s Founder and Chairman, commented, “Spinal Modulation has made significant progress in the development of the company’s technology. I am confident that the company’s commitment to excellence in clinical research will lead to additional tools for the treatment of chronic pain.”

About Spinal Modulation

Spinal Modulation, headquartered in Menlo Park, California, is an early stage, privately held medical device company developing the next generation spinal cord stimulator system for the treatment of chronic pain. Spinal Modulation has now completed development of its first fully implantable spinal cord stimulation system for the treatment of chronic pain and has initiated clinical studies internationally to further advance its technology.



   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->